Show simple item record

dc.contributor.authorMantovani, Andrea
dc.contributor.authorNaghavi, Alireza
dc.date.accessioned2010-10-25T20:09:50Z
dc.date.available2010-10-25T20:09:50Z
dc.date.issued2009-10-08
dc.identifier.urihttp://hdl.handle.net/1853/35515
dc.descriptionPresented at GLOBELICS 2009, 7th International Conference, 6-8 October, Dakar, Senegal.en_US
dc.descriptionParallel session 5: Globalisation, IP and innovation in biotech and pharmaceuticals
dc.description.abstractThis paper studies how South-South parallel import (PI) affects cost reducing R&D effort by heterogeneous firms located in an emerging country. Specifically, when a technologically inferior firm moves to exploit a new unregulated Southern market, the impact of PI on innovation is determined by the degree of heterogeneity between firms and trade policy. Innovation by one or both firms may increase when the technological gap between firms is low and tariffs are sufficiently large. PI can also enhance social welfare by creating stimulus for innovation.en_US
dc.language.isoen_USen_US
dc.publisherGeorgia Institute of Technologyen_US
dc.relation.ispartofseriesGLOBELICS09. Session 5en_US
dc.subjectIntellectual property rightsen_US
dc.subjectParallel importsen_US
dc.subjectInnovationen_US
dc.subjectTariffsen_US
dc.subjectWelfareen_US
dc.titleSouth-South Parallel Import and Cost Reducing Innovation in the Pharmaceutical Industry: An Alternative Approachen_US
dc.typeProceedingsen_US
dc.contributor.corporatenameUniversità di Bologna. Dipartimento di Scienze Economiche


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record